Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: Inhibitors of CDK f...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors

Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors

Bibliographic Details
Main Authors: Andrea Cavazzoni, Arianna Palladini
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
CDK
solid tumors
pre-clinical
combination
Rb
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/full

Similar Items

  • Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells
    by: Chao-Yue Sun, et al.
    Published: (2022-06-01)
  • CDK4/6 inhibitor PD0332991 in glioblastoma treatment: does it have a future?
    by: Lisette eSchroder, et al.
    Published: (2015-11-01)
  • Wogonin Induces Apoptosis and Reverses Sunitinib Resistance of Renal Cell Carcinoma Cells via Inhibiting CDK4-RB Pathway
    by: Yong Wang, et al.
    Published: (2020-07-01)
  • Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma
    by: Zhong-Kun Xia, et al.
    Published: (2021-07-01)
  • The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study
    by: Elisa Rossini, et al.
    Published: (2024-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs